Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Deficient Metabolic Health Spikes Obesity Related Cancer

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Precision Diagnostics Accelerating Early Detection

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

As per a recently conducted research, people who have a poor metabolic health happen to be at a higher risk of certain form of cancer irrespective of the fact that what their body weight is.

This study has followed around 800,000 people across Norway, Sweden, and Austria for the last 40 years with an eye on their body mass index as well as metabolic health. The study tracked the individuals’ blood glucose levels, blood fats, as well as blood pressure. Now, the scientists have used this data to comprehend how these elements affect obesity-related cancer risks.

It is already a known fact that obesity is associated with ten different kinds of cancer. As part of a European collaboration led by Lund University, scientists have studied the bond between body weight, metabolic health, and cancer. This study has got itself published in the journal of National Cancer Institute.

The researchers took consideration of the data from health surveys as well as national registries that contained information on 800,000 people across 1972-2014. The data on blood glucose, blood fats in the form of triglycerides, and blood pressure were used, allowing the scientists to gauge if the people were considered metabolically healthy or not. The participants were also segregated based on the fact that whether they were normal weight, overweight, or fell under the obese category.

Tanja Stocks, the epidemiology scientist who led the study, revealed that being obese is more often linked to being metabolically unhealthy, but one also doesn’t have to be overweight to have a metabolically unhealthy status. Hence, it makes sense to conduct research on how this status plays a role in the bond between obesity-related cancer and the BMI. 

In the 40-year follow-up period, 23,630 people were diagnosed with obesity-related cancer, and as the scientists expected, those individuals with a higher BMI had an increased risk of cancer, as did those with poor metabolic health.

The highest rate of risk was found in people who had poor metabolic health and were obese as well. This combination was particularly associated with a high risk of liver and kidney cancer and, in women, endometrial cancer.

As per the researchers, poor metabolic health also led to a high risk of cancer related to obesity regardless of whether the participant had a normal weight, was overweight, or was obese.

That said, the research was not able to identify the cause of these associations. The researchers did find that metabolic health and obesity gelled in a way that caused a surge in the risk of certain cancers more than what was thought previously. The study brings out the fact the significance of analysing varied kinds of metabolic risk profiles besides obesity so as to be able to pin-point the group that can take away the most from these interventions and thereby reduce the chances of suffering from cancers related to obesity, remarked the first author of the study, Ming Sun.

Latest stories

Related stories

Biotech Innovation Strengthening Clinical Pipelines

The discovery and development of next-generation therapies are being propelled by a fundamental leap in our understanding of molecular biology and cellular mechanics. By bridging the gap between laboratory research and clinical application, the life sciences sector is creating a robust stream of precision treatments that offer new hope for previously intractable conditions.

Precision Diagnostics Accelerating Early Detection

The fundamental strategy of clinical medicine is shifting from managing symptoms to identifying the earliest molecular indicators of disease. By integrating sophisticated genomic analysis with high-fidelity imaging, practitioners are now able to intercept pathological processes long before they manifest as systemic illness, significantly improving the efficacy of therapeutic interventions.

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse Bone Graft in TLIF

Medtronic announced that it has secured FDA premarket approval...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »